Related Experiment Video
Updated: Dec 3, 2025
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
Construction and Characterization of KRAS Immune Lipid Magnetic Balls for Colorectal Cancer Circulating Tumor Cells
Chengbao Feng1, Jingjing Wang1, Xue Yang2
1Department of Medical Oncology, No. 2 Hospital of Baoding, Baoding City, People's Republic of China.
Objective:
The purpose of this study was to prepare and characterize a lipid magnetic ball modified with KRAS antibodies on the surface and to isolate circulating tumor cells of colorectal cancer with KRAS mutations.
Methods:
The microemulsion method was used to form lipid bilayers to encapsulate Fe3O4 nanoparticles with superparamagnetism to form lipid magnetic balls, and KRAS antibodies were formed on the surface to form KRAS immune lipid magnetic balls.
Results:
Compared with traditional EpCAM antibody-modified lipid magnetic balls, it can effectively improve the capture ability of colorectal cancer circulating tumor cells with KRAS mutation, the capture rate reaches 92.9%, and the capture results are consistent with clinical diagnosis and pathology.
Conclusion:
Our results showed that KRAS antibody-modified lipid magnetic balls can be used in the diagnosis and treatment of KRAS colorectal cancer.
Insights
New KRAS antibody-modified lipid magnetic balls effectively capture colorectal cancer cells with KRAS mutations. This advancement shows promise for improved diagnosis and treatment of KRAS-mutated colorectal cancer.
Area of Science:
- Biotechnology
- Nanotechnology
- Oncology
Background:
- Colorectal cancer (CRC) is a significant global health concern.
- Early and accurate detection of specific mutations, such as KRAS mutations, is crucial for effective treatment strategies.
- Circulating tumor cells (CTCs) offer a minimally invasive window into tumor biology and progression.
Purpose of the Study:
- To develop and characterize novel lipid magnetic balls functionalized with KRAS antibodies.
- To assess the efficacy of these KRAS-targeted magnetic balls in isolating CTCs from colorectal cancer patients with KRAS mutations.
Main Methods:
- Utilized a microemulsion method to create lipid bilayers encapsulating superparamagnetic Fe3O4 nanoparticles, forming lipid magnetic balls.
- Surface modification of these balls with KRAS antibodies to create KRAS immune lipid magnetic balls.
Main Results:
- KRAS antibody-modified lipid magnetic balls demonstrated superior capture efficiency for KRAS-mutated colorectal cancer CTCs compared to EpCAM antibody-modified balls.
- Achieved a high capture rate of 92.9% for target CTCs.
- The capture results showed strong concordance with clinical diagnosis and pathological findings.
Conclusions:
- KRAS antibody-modified lipid magnetic balls represent a promising tool for the diagnosis and treatment of KRAS-mutated colorectal cancer.
- This targeted approach enhances the isolation of specific CTCs, potentially improving patient stratification and therapeutic decisions.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013